Park Si-Hoon, Shim Kyung-Won
Department of Cardiology and Ewha Medical Research Institute, Ewha Womans University College of Medicine, Mokdong Hospital, 911-1 Mok-dong, Yangcheon-gu, Seoul 158-710, Korea.
Yonsei Med J. 2005 Aug 31;46(4):511-8. doi: 10.3349/ymj.2005.46.4.511.
Because obesity is frequently complicated by other cardiovascular risk factors, the impact of a reduction in visceral adiposity on vascular endothelial dysfunction (VED) in obese patients is difficult to determine. In the present study, we evaluated the impact of a reduction in visceral adiposity on VED in obese women. Thirty-six premenopausal obese women (BMI >/= 25 kg/m2) without complications were enrolled in the study. VED was evaluated by determining the augmentation index (AIx) from radial artery pulse waves obtained by applanation tonometry. Changes in AIx in response to nitroglycerin- induced endothelium-independent vasodilatation (DeltaAIx-NTG) and in response to salbutamol administration (DeltaAIx-Salb) were determined before and after weight reduction. After a 12-week weight reduction program, the average weight loss was 7.96 +/- 3.47 kg, with losses of 21.88 +/- 20.39 cm2 in visceral fat areas (p < 0.001). Pulse wave analysis combined with provocative pharmacological testing demonstrated preserved endothelium-independent vasodilation in healthy premenopausal obese women (DeltaAIx-NTG: 31.36 +/- 9.80% before weight reduction vs. 28.25 +/- 11.21% after weight reduction, p > 0.1) and an improvement in endothelial-dependent vasodilation following weight reduction (DeltaAIx-Salb: 10.03 +/- 6.49% before weight reduction vs. 19.33 +/- 9.28% after reduction, p < 0.001). A reduction in visceral adipose tissue was found to be most significantly related to an increase in DeltaAIx-Salb (beta=-0.57, p < 0.001). A reduction in visceral adiposity was significantly related to an improvement in VED. This finding suggests that reduction of visceral adiposity may be as important as the control of other major risk factors in the prevention of atherosclerosis in obese women.
由于肥胖常伴有其他心血管危险因素,因此很难确定内脏脂肪减少对肥胖患者血管内皮功能障碍(VED)的影响。在本研究中,我们评估了内脏脂肪减少对肥胖女性VED的影响。36名无并发症的绝经前肥胖女性(BMI≥25kg/m²)被纳入研究。通过应用压平式眼压计从桡动脉脉搏波中测定增强指数(AIx)来评估VED。在体重减轻前后,分别测定了对硝酸甘油诱导的非内皮依赖性血管舒张(ΔAIx-NTG)和沙丁胺醇给药(ΔAIx-Salb)的AIx变化。经过12周的体重减轻计划后,平均体重减轻了7.96±3.47kg,内脏脂肪面积减少了21.88±20.39cm²(p<0.001)。脉搏波分析结合激发药理学测试表明,健康的绝经前肥胖女性的非内皮依赖性血管舒张功能得以保留(ΔAIx-NTG:体重减轻前为31.36±9.80%,体重减轻后为28.25±11.21%,p>0.1),并且体重减轻后内皮依赖性血管舒张功能得到改善(ΔAIx-Salb:体重减轻前为10.03±6.49%,体重减轻后为19.33±9.28%,p<0.001)。发现内脏脂肪组织的减少与ΔAIx-Salb的增加最为显著相关(β=-0.57,p<0.001)。内脏脂肪减少与VED的改善显著相关。这一发现表明,在内脏肥胖女性预防动脉粥样硬化方面,减少内脏脂肪可能与控制其他主要危险因素同样重要。